Full Press Release Details
NEW HOPE, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management will present and be available for one-on-one meetings at multiple conferences throughout November and Deccember.
Details on the presentations are shown below.
Jefferies London Healthcare Conference
Format: Corporate presentation
Date: November 14, 2023
Piper Sandler Healthcare Conference
Format: Corporate presentation
Date: November 29, 2023
Mizuho Med Devices Summit
Format: 1x1 Meetings Only
Date: December 6, 2023
A live audio webcast of the presentation can be accessed through the Investor Relations section of the Company’s website at https://investors.orchestrabiomed.com/news-events/events. An archived replay of the webcast will be available on the Company’s website for 90 days following the live event.
About Orchestra BioMed
References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.